Invesco Portfolio holdings
Invesco is an investment management company that launched the Invesco QQQ exchange-traded fund in 1999, back when it operated as Amvescap. Invesco QQQ tracks the Nasdaq-100 index of companies listed on Nasdaq. Invesco traces its roots to H. Lotery & Co., a UK advisory firm formed in 1935, and in 1978 Charles Brady and eight partners bought the money management arm of Citizens & Southern National Bank, then called INVESCO. It bought PowerShares Capital Management, sponsor of 36 exchange-traded funds, in 2006, and in 2007 it went back to the Invesco name and moved its legal home to Bermuda. Its 2009 purchase of Morgan Stanley's retail unit brought in Van Kampen Investments, and in 2019 it acquired OppenheimerFunds from Massachusetts Mutual Life Insurance Company. It serves retail and institutional investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Sandisk
SNDK
|
+$6.35B |
| 2 |
HONA
Honeywell Aerospace
HONA
|
+$2.84B |
| 3 |
Arm
ARM
|
+$1.84B |
| 4 |
Lumentum
LITE
|
+$1.78B |
| 5 |
Teradyne
TER
|
+$1.57B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco NASDAQ 100 ETF
QQQM
|
+$2.26B |
| 2 |
Invesco S&P 500 Equal Weight ETF
RSP
|
+$2.2B |
| 3 |
Honeywell
HON
|
+$2.2B |
| 4 |
Dell
DELL
|
+$1.69B |
| 5 |
Insmed
INSM
|
+$744M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 44.02% |
| 2 | Consumer Discretionary | 9.38% |
| 3 | Communication Services | 9.23% |
| 4 | Industrials | 8.59% |
| 5 | Healthcare | 7.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2276
Franklin Limited Duration Income Trust
FTF
$219M
| $4.01M | ﹤0.01% |
692,417
+1,906
| +0.3% | +$11.2K |
2013 Q2
52 quarters
|
|
2277
Safehold
SAFE
$800M
| $4M | ﹤0.01% |
254,589
-3,803
| -1% | -$57.6K |
2013 Q2
52 quarters
|
|
2278
Almonty Industries
ALM
$2.51B
| $3.99M | ﹤0.01% |
+241,091
| New | +$4.6M |
2026 Q2
0 quarters
|
|
2279
Onterris Inc
ONT
$524M
| $3.99M | ﹤0.01% |
197,296
+15,796
| +9% | +$295K |
2021 Q1
21 quarters
|
|
|
WSR
2280
DELISTED
Whitestone REIT
WSR
| $3.96M | ﹤0.01% |
208,831
-44,341
| -18% | -$833K |
2013 Q2
52 quarters
|
|
2281
Universal Insurance Holdings
UVE
$1.34B
| $3.96M | ﹤0.01% |
95,716
-3,239
| -3% | -$122K |
2013 Q2
52 quarters
|
|
2282
Ingles Markets
IMKTA
$1.6B
| $3.95M | ﹤0.01% |
44,613
-6,191
| -12% | -$553K |
2013 Q2
52 quarters
|
|
2283
Herc Holdings
HRI
$5.55B
| $3.92M | ﹤0.01% |
27,375
-2,038,695
| -99% | -$263M |
2013 Q2
52 quarters
|
|
2284
Seadrill
SDRL
$3.29B
| $3.91M | ﹤0.01% |
103,325
+56,100
| +119% | +$2.61M |
2023 Q2
12 quarters
|
|
2285
Bloomin' Brands
BLMN
$905M
| $3.91M | ﹤0.01% |
427,259
-45,090
| -10% | -$328K |
2013 Q2
52 quarters
|
|
2286
Constellium
CSTM
$3.11B
| $3.89M | ﹤0.01% |
122,064
-13,921
| -10% | -$449K |
2014 Q1
49 quarters
|
|
2287
Towne Bank
TOWN
$3.43B
| $3.87M | ﹤0.01% |
106,791
+9,053
| +9% | +$316K |
2013 Q2
52 quarters
|
|
2288
Nuveen Core Equity Alpha Fund
JCE
$283M
| $3.87M | ﹤0.01% |
236,535
-25,064
| -10% | -$402K |
2014 Q1
49 quarters
|
|
2289
Frontier Group Holdings
ULCC
$1.49B
| $3.87M | ﹤0.01% |
488,669
+224,671
| +85% | +$1.16M |
2021 Q2
20 quarters
|
|
2290
Turning Point Brands
TPB
$1.35B
| $3.86M | ﹤0.01% |
45,507
-503
| -1% | -$41.8K |
2018 Q2
32 quarters
|
|
2291
Virtus Investment Partners
VRTS
$783M
| $3.84M | ﹤0.01% |
26,782
-3,022
| -10% | -$427K |
2013 Q2
52 quarters
|
|
2292
Zeta Global
ZETA
$7.82B
| $3.84M | ﹤0.01% |
195,174
+8,863
| +5% | +$164K |
2022 Q2
16 quarters
|
|
2293
Celldex Therapeutics
CLDX
$2.36B
| $3.84M | ﹤0.01% |
103,131
+9,447
| +10% | +$305K |
2021 Q1
21 quarters
|
|
2294
STAAR Surgical
STAA
$1.23B
| $3.83M | ﹤0.01% |
133,417
-15,610
| -10% | -$434K |
2018 Q1
33 quarters
|
|
2295
FIVE9
FIVN
$2.72B
| $3.82M | ﹤0.01% |
179,351
-24,499
| -12% | -$484K |
2016 Q1
41 quarters
|
|
2296
Trupanion
TRUP
$1.32B
| $3.81M | ﹤0.01% |
153,933
+15,982
| +12% | +$388K |
2020 Q1
25 quarters
|
|
2297
Grupo Cibest SA
CIB
$21.7B
| $3.81M | ﹤0.01% |
47,989
-421
| -0.9% | -$30.4K |
2013 Q2
52 quarters
|
|
2298
Zevra Therapeutics
ZVRA
$610M
| $3.79M | ﹤0.01% |
264,389
+231,515
| +704% | +$2.57M |
2023 Q2
12 quarters
|
|
2299
Schrodinger
SDGR
$2.03B
| $3.74M | ﹤0.01% |
230,201
+21,262
| +10% | +$284K |
2020 Q4
22 quarters
|
|
2300
Uranium Energy
UEC
$3.82B
| $3.74M | ﹤0.01% |
350,845
+18,639
| +6% | +$250K |
2020 Q1
25 quarters
|
|
Similar funds
Invesco's Q2 2026 Portfolio in Review
As of Q2 2026, Invesco held 3,969 positions worth $1.26T, up 23% from $1.02T the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Invesco's Q2 2026 filing shows 214 new, 1,806 increased, 1,705 reduced and 150 closed positions. Its largest new stake was Honeywell Aerospace: 12,884,435 shares worth $2.85B. The largest sale was Invesco NASDAQ 100 ETF, an estimated $2.26B.
By sector, the portfolio is most concentrated in Technology at 44% of assets, up from 35% a quarter earlier, followed by Consumer Discretionary and Communication Services.
- Invesco's largest Q2 2026 buy was Honeywell Aerospace: 12,884,435 shares worth $2.85B.
- Invesco added most to Sandisk in Q2 2026, an estimated $6.35B increase.
- Invesco's biggest Q2 2026 reduction was Invesco NASDAQ 100 ETF, cutting an estimated $2.26B.
- Invesco fully exited Coterra Energy in Q2 2026, selling an estimated $394M.
- Invesco's ten largest holdings make up 29% of its $1.26T portfolio in Q2 2026.
- Invesco opened 214 new positions and closed 150 in Q2 2026.
- Invesco's portfolio value rose 23% quarter-over-quarter to $1.26T.
Based on Invesco's 13F filing for Q2 2026, filed 14 Aug 2026.